We then applied our approach to individual cells from the ER-/PR-/HER2+ breast cancer cell line CRL2338/HCC1954 as well as matched normal B-lymphoblasts (CRL2339/HCC1954BL) isolated from the same individual. This evidence concerns the gene ERBB2 and breast carcinoma.